| Recruiting | Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis. Moderate to Severe Atopic Dermatitis | Phase 3 | 2024-02-27 |
| Recruiting | Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | Phase 1 | 2024-02-01 |
| Active Not Recruiting | Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory A Steroid-refractory Acute Graft-versus-host Disease | Phase 2 | 2023-11-13 |
| Recruiting | Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Ava Steroid-refractory Acute Graft-versus-host Disease | Phase 3 | 2021-08-16 |
| Terminated | PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia Acute B-Cell Lymphoblastic Leukaemia | Phase 2 | 2019-04-26 |
| Completed | Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies | Phase 2 | 2015-04-01 |
| Completed | Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) | Phase 2 | 2014-11-21 |
| Completed | Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis Juvenile Idiopathic Arthritis | EARLY_Phase 1 | 2014-04-01 |
| Completed | Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen Psoriasis | Phase 1 | 2013-05-01 |
| Completed | Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis Rheumatoid Arthritis (RA) | Phase 1 | 2012-10-01 |
| Completed | Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA) Rheumatoid Arthritis | Phase 3 | 2012-07-01 |
| Terminated | Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnose Acute Lymphoblastic Leukaemia | Phase 1 / Phase 2 | 2011-01-01 |
| Completed | Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia ( Acute Lymphoid Leukemia | Phase 2 | 2009-07-01 |
| Completed | Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 3 | 2008-11-24 |
| Completed | Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute L Acute Lymphoblastic Leukemia | Phase 3 | 2008-10-01 |
| Terminated | Urokinase Therapy in Patients With Diabetic Foot Syndrome Diabetic Foot, Arterial Occlusive Disease, Ischemia | Phase 3 | 2008-06-01 |
| Completed | Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS) Myelodysplastic Syndrome | Phase 2 | 2004-11-01 |
| Completed | Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) Acute Myeloid Leukaemia | Phase 2 | 2004-03-01 |
| Completed | Urokinase Therapy in Diabetic Foot Syndrome Diabetic Foot, Arterial Occlusive Disease, Ischemia | Phase 2 | 2002-02-01 |
| Completed | Dose-range Finding Treosulfan-based Conditioning Hematological Malignancies | Phase 1 / Phase 2 | 2001-11-01 |
| Completed | Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant G Brain Neoplasm | Phase 1 / Phase 2 | 2000-02-01 |
| Completed | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid Brain Cancer, Brain Tumors, Cancer of Brain | Phase 3 | 1999-10-01 |